ALSE
Alseres Pharmaceuticals, Inc.
Other OTC
People also watch:ADLSAMARCAPSKDUSPARD
65.000.00 (0.00%)
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Prev Close65.00
Open0.00
Bid0.00 x
Ask0.00 x
52wk Range
Day's Range0.00 - 0.00
Volume0
Avg Vol (3m)0
As of 11:46 AM EDT. Market closed.
  • Alseres Pharmaceuticals, Inc. – Value Analysis (US OTC:ALSE) : October 23, 2015
    Capital Cube9 months ago

    Alseres Pharmaceuticals, Inc. – Value Analysis (US OTC:ALSE) : October 23, 2015

    Capitalcube gives Alseres Pharmaceuticals, Inc. a score of 25.Our analysis is based on comparing Alseres Pharmaceuticals, Inc. with the following peers – Threshold Pharmaceuticals, Inc., Cortex Pharmaceuticals, Inc., Navidea Biopharmaceuticals, Inc., IMRIS Inc., Eli Lilly and Company, International Isotopes Inc., Synthetic Biologics, Inc., Fonar Corporation, iCAD, Inc. and General Electric Company (THLD-US, CORX-US, NAVB-US, IMRSQ-US, […] (Read more...) The post Alseres Pharmaceuticals, Inc. – Value Analysis (US OTC:ALSE) : October 23, 2015 appeared first on CapitalCube.

  • We're sorry this is all we were able to find about this topic.